All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-YC0995 | Human anti-PM T cell receptor (1.22), pCDTCR1 | Mycobacteria | 1.22 | Human | Phosphomycoketide | human CD1c | Lentiviral vector | |
TCR-YC0996 | Human anti-PM T cell receptor (1.6), pCDTCR1 | Mycobacteria | 1.6 | Human | Phosphomycoketide | human CD1c | Lentiviral vector | |
TCR-YC0997 | Human anti-PM T cell receptor (2.4), pCDTCR1 | Mycobacteria | 2.4 | Human | Phosphomycoketide | human CD1c | Lentiviral vector | |
TCR-YC0998 | Human anti-PM T cell receptor (22.2), pCDTCR1 | Mycobacteria | 22.2 | Human | Phosphomycoketide | human CD1c | Lentiviral vector | |
TCR-YC0999 | Human anti-PM T cell receptor (22.5), pCDTCR1 | Mycobacteria | 22.5 | Human | Phosphomycoketide | human CD1c | Lentiviral vector | |
TCR-YC1000 | Human anti-PM T cell receptor (DN6), pCDTCR1 | Mycobacteria | DN6 | Human | Phosphomycoketide | human CD1c | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION